Home › Funds › Venrock Adviser, LLC › ACHV
Venrock Adviser, LLC position in ACHV
ACHIEVE LIFE SCIENCE INC · Health Care
Venrock Adviser, LLC reported holding 5,502,064 shares of ACHV (ACHIEVE LIFE SCIENCE INC) in its Q3 2026 13F filing — a position valued at US$44.5M, representing 2.16% of its reported portfolio and ranking #14 among its reported holdings. Venrock Adviser, LLC has disclosed ACHV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's ACHV position evolved
Venrock Adviser, LLC first disclosed a stake in ACHV in Q2 2026 at 2,751,032 shares (US$18.0M). The position peaked in Q3 2026 at 5,502,064 shares, worth US$44.5M. Across 2 filings, Venrock Adviser, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,502,064 shares valued at US$44.5M — an increase of 2,751,032 shares quarter over quarter.. Notable position changes include a 100% increase in Q3 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 2.75M | $17.96M | New |
| Q3 2026 | 5.50M | $44.51M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ACHV and 13F data
ACHV (ACHIEVE LIFE SCIENCE INC) is a Health Care company. 70 other funds we track also report a position in ACHV — the largest reported positions include Frazier Life Sciences Management, L.P. (US$61.6M), TPG GP A, LLC (US$55.6M), venBio Partners LLC (US$47.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACHV
- Frazier Life Sciences Management, L.P. 7.61M sh · $61.60M · Q3 2026
- TPG GP A, LLC 6.88M sh · $55.64M · Q3 2026
- venBio Partners LLC 5.91M sh · $47.85M · Q3 2026
- Paradigm Biocapital Advisors LP 4.95M sh · $40.06M · Q3 2026
- Propel Bio Management, LLC 3.86M sh · $31.26M · Q3 2026
- Vivo Capital, LLC 2.75M sh · $22.26M · Q3 2026
- Boxer Capital Management, LLC 2.15M sh · $17.39M · Q3 2026
- Logos Global Management LP 1.00M sh · $8.09M · Q3 2026
- Simplify Asset Management Inc. 932.11K sh · $7.54M · Q3 2026
- Spruce Street Capital LP 736.64K sh · $5.96M · Q3 2026
- KVP Capital Advisors, LP 462.36K sh · $3.74M · Q3 2026
- Blue Owl Capital Holdings LP 412.65K sh · $3.34M · Q3 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held ACHV?
Venrock Adviser, LLC has disclosed ACHV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Venrock Adviser, LLC's current position in ACHV?
As of Q3 2026, Venrock Adviser, LLC holds 5.50M shares of ACHV (ACHIEVE LIFE SCIENCE INC), valued at $44.51M, representing 2.16% of its reported portfolio and ranking #14.
Has Venrock Adviser, LLC been buying or selling ACHV?
In the latest 13F filing (Q3 2026), Venrock Adviser, LLC increased its position in ACHV. The position peaked in Q3 2026 at 5.50M shares.
Which other funds hold ACHV?
Other major institutional holders of ACHV include Frazier Life Sciences Management, L.P., TPG GP A, LLC, venBio Partners LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.